COMMUNIQUÉS West-GlobeNewswire

Kiadis Pharma Strengthens Management Team

05/03/2019 - 17:46

Kiadis Pharma Strengthens Management Team Dirk de Naeyer appointed Chief Operations Officer and Martine Nolan as Head of Quality Assurance, effective March 1, 2019 Amsterdam, The Netherlands, March 5, 2019 - Kiadis [...]

Infant Bacterial Therapeutics AB announces first distribution agreement

05/03/2019 - 17:10

Infant Bacterial Therapeutics AB has today signed the first distribution agreement for IBP-9414 with Megapharm Ltd. for the Israeli market and the Palestinian Authority’s territories. The agreement gives MegaPharm [...]

BrainsWay Announces New Clinical Support Program for Physicians Treating Obsessive-Compulsive Disorder: – “BrainsWay OCD Launchpad to Success”

05/03/2019 - 17:09

Program supports physicians in successfully implementing OCD Deep TMS treatment, through in-depth clinical guidance and patient awareness campaigns HACKENSACK, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. ( [...]

Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market

05/03/2019 - 16:56

TORONTO, ON, March 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) announces that it has signed an agreement to acquire a commercial bakery with existing revenues and projected [...]

B. Braun Displays Ongoing Commitment to Home and Specialty Infusion Therapy at NHIA 2019

05/03/2019 - 16:25

BETHLEHEM, Pa., March 05, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. will showcase its extensive portfolio of products, services, and technology at this year’s National Home Infusion Association (NHIA) Conference [...]

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

05/03/2019 - 15:51

Orphazyme A/S Company announcement No. 07/2019 Company Registration No. 32266355 Copenhagen, Denmark, March 5, 2019 – Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 (“Orphazyme”), [...]

Olainfarm Holds Fourth Quarter 2018 Investor Conference - Webinar

05/03/2019 - 15:34

AS Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference - webinar scheduled on March 5, 2019 at 16:00 (EET). To join the webinar please follow the [...]

Eloxx Pharmaceuticals to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019

05/03/2019 - 15:08

WALTHAM, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]

RepScrubs® Appoints Former CMS Administrative Director, Charlene Frizzera to Advisory Board to Continue Improving Infection Control in Hospitals

05/03/2019 - 15:05

Company limiting the transfer of pathogens in operating rooms expands advisory board to include former COO at The Center for Medicare and Medicaid Services ORLANDO, Fla., March 05, 2019 (GLOBE NEWSWIRE) -- Prescient [...]

Sienna Biopharmaceuticals to Present at Cowen and Company Health Care Conference

05/03/2019 - 15:05

WESTLAKE VILLAGE, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that Frederick C. Beddingfield III, M.D., Ph.D., [...]

Oxford Immunotec to Participate in Two Upcoming Investor Conferences

05/03/2019 - 15:00

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, [...]

Predictive Technology Group Sponsors 5th Annual Perinatal Stem Cell Society Congress

05/03/2019 - 15:00

SALT LAKE CITY, March 05, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through [...]

FemPulse Appoints Dr. Robert Kieval as Chief Scientific and Clinical Officer

05/03/2019 - 15:00

MINNEAPOLIS, March 05, 2019 (GLOBE NEWSWIRE) -- FemPulse Corporation (FemPulse), a private, clinical-stage bioelectronic medicine company developing a novel therapy for the personalized treatment of overactive bladder ( [...]

NSS Labs Announces 2019 Advanced Endpoint Protection Group Test Results at the RSA Conference in San Francisco

05/03/2019 - 15:00

Testing Reveals Improvement in Security Effectiveness and Evasion Block Rates AUSTIN, Texas, March 05, 2019 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, security product [...]

iTeos Therapeutics to Participate in Upcoming U.S. Conferences in March

05/03/2019 - 14:30

Gosselies, Belgium - March 5, 2019 - iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announced that Michel Detheux, Ph.D., Chief Executive Officer of iTeos, will present in [...]

BrainsWay Expands Intellectual Property Position by Obtaining Rights to Multi-Channel Transcranial Magnetic Stimulation Patent Portfolio

05/03/2019 - 14:30

Acquires Multi-Channel TMS Patent Portfolio from TMS Innovations Enters into an Exclusive Option Agreement with Stanford University to License Additional Multi-Channel TMS Patents BrainsWay is Currently Developing a [...]

Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance

05/03/2019 - 14:30

Top-line Data Readout Expected in early Q4 2019 LOS ANGELES, March 05, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative [...]

Precision Therapeutics’ Skyline Medical Division Captures Market Share in Saudi Arabia Via New Orders While Disposable Sales Show Significant Year-Over-Year Increase

05/03/2019 - 14:30

Company Concluded 2018 With 38 Percent Increase in STREAMWAY System Disposables MINNEAPOLIS, March 05, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced [...]

Arbitration Decision With SDC Entities Requires Align to Close Invisalign Stores

05/03/2019 - 14:30

Expects to Incur a Material Charge in the First Quarter Expects Minimal Impact on Align Revenues No Bearing on Long-Held Strategy to Connect Millions of Consumers with Invisalign Doctors SAN JOSE, Calif., March 05, 2019 [...]